Skip to content

video not played or not found error
click on direct switch

Hosted by Dailymotion. For legal issues: Copyright Center · DMC · Instant Removal

Latest stem-cell research.

R
Ron Gorton

36 Views • Mar 07, 2013

Description

02/04/13 -- International Stem Cell Corporation (OTCQB: ISCO)
(www.internationalstemcell.com) (ISCO or the Company) a California-based biotechnology
company, today announced positive 12-week results from its pre-clinical in vivo
Parkinson's disease study. The primary goal of this behavioral study was to demonstrate
the therapeutic benefits of neuronal cells derived from human parthenogenetic stem cell
(hpSC) line in a rat model of Parkinson's disease (PD).